Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (911-920 of 1,467) with videos related to

Pageof 147
Sort By:
Arthritis and Rheumatism|March 31, 2007
Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioningTanja A Stamm, Valerie Nell, Mona Mathis, et al.
International Archives of Allergy and Immunology|September 6, 2000
Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodiesW R Sperr, S Natter, M Baghestanian, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2006
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconMichael Overholtzer, Jianmin Zhang, Gromoslaw A Smolen, et al.
Nature Cell Biology|November 26, 2009
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathwayJianmin Zhang, Jun-Yuan Ji, Min Yu, et al.
Annals of the Rheumatic Diseases|July 27, 2012
Rituximab in psoriatic arthritis: an exploratory evaluationEsther Jimenez-Boj, Tanja A Stamm, Martina Sadlonova, et al.
Rheumatology (Oxford, England)|January 4, 2001
Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosisG H Stummvoll, M Aringer, J S Smolen, et al.
Arthritis and Rheumatism|January 22, 2000
Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxisH P Kiener, R Hofbauer, M Tohidast-Akrad, et al.
British Journal of Rheumatology|June 1, 1995
A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trialG Wylie, T Appelboom, W Bolten, et al.
Arthritis and Rheumatism|September 6, 2005
Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: involvement of impaired integrin activation and immunologic synapse formationMaximilian Zeyda, Marko Poglitsch, René Geyeregger, et al.
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Pageof 147

Showing results (911-920 of 1,467) with videos related to

Sort By:
Pageof 147
Arthritis and Rheumatism|March 31, 2007
Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioningTanja A Stamm, Valerie Nell, Mona Mathis, et al.
International Archives of Allergy and Immunology|September 6, 2000
Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodiesW R Sperr, S Natter, M Baghestanian, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2006
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconMichael Overholtzer, Jianmin Zhang, Gromoslaw A Smolen, et al.
Nature Cell Biology|November 26, 2009
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathwayJianmin Zhang, Jun-Yuan Ji, Min Yu, et al.
Annals of the Rheumatic Diseases|July 27, 2012
Rituximab in psoriatic arthritis: an exploratory evaluationEsther Jimenez-Boj, Tanja A Stamm, Martina Sadlonova, et al.
Rheumatology (Oxford, England)|January 4, 2001
Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosisG H Stummvoll, M Aringer, J S Smolen, et al.
Arthritis and Rheumatism|January 22, 2000
Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxisH P Kiener, R Hofbauer, M Tohidast-Akrad, et al.
British Journal of Rheumatology|June 1, 1995
A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trialG Wylie, T Appelboom, W Bolten, et al.
Arthritis and Rheumatism|September 6, 2005
Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: involvement of impaired integrin activation and immunologic synapse formationMaximilian Zeyda, Marko Poglitsch, René Geyeregger, et al.
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Pageof 147